Literature DB >> 17052503

Erythroplasia of Queyrat treated with imiquimod 5% cream.

Giuseppe Micali1, Maria Rita Nasca, Rocco De Pasquale.   

Abstract

Imiquimod is an immune response-modifying agent with potent antiviral and antitumor activity effective in the treatment of various skin disorders, including in situ carcinoma of the skin (Bowen's disease). The case of a 64-year-old man affected by an in situ carcinoma of the glans mucosa, namely erythroplasia of Queyrat, successfully treated with imiquimod 5% cream is described. Because the results of tests for human papillomavirus infection were negative in this case, we suggest that imiquimod may have acted through an antitumor effect mediated by cytokine activation. This compound may represent an alternative treatment in patients with erythroplasia of Queyrat, although the dosing schedule and treatment duration require further evaluation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052503     DOI: 10.1016/j.jaad.2006.07.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision.

Authors:  Jee Woong Choi; Mira Choi; Kwang Hyun Cho
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 2.  Erythroplasia of Queyrat treated by laser and light modalities: a systematic review.

Authors:  Eric L Maranda; Austin H Nguyen; Victoria M Lim; Vidhi V Shah; Joaquin J Jimenez
Journal:  Lasers Med Sci       Date:  2016-06-21       Impact factor: 3.161

3.  Erythroplasia of queyrat.

Authors:  Deirdre Mary Fanning; Hugh Flood
Journal:  Clin Pract       Date:  2012-06-07

4.  Queyrat erythroplasia accompanied by bladder cancer in a circumcised male.

Authors:  Savaş Öztürk; Haydar Uçak
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

5.  Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects.

Authors:  Maria Isabel Ramos Saraiva; Larissa Karine Leite Portocarrero; Marcella Amaral Horta Barbosa Vieira; Bethania Cabral Cavalli Swiczar; Andrezza Telles Westin
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

Review 6.  HPV Carcinomas in Immunocompromised Patients.

Authors:  Nicole M Reusser; Christopher Downing; Jacqueline Guidry; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

Review 7.  Penile-sparing modalities in the management of low-stage penile cancer.

Authors:  Paurush Babbar; Nitin Yerram; Alice Crane; Daniel Sun; Kyle Ericson; Andrew Sun; Abhinav Khanna; Hadley Wood; Andrew Stephenson; Kenneth Angermeier
Journal:  Urol Ann       Date:  2018 Jan-Mar

Review 8.  Soluble Factors and Receptors Involved in Skin Innate Immunity-What Do We Know So Far?

Authors:  Lucian G Scurtu; Olga Simionescu
Journal:  Biomedicines       Date:  2021-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.